We are delighted to announce Retrophin as a Bronze level sponsor of the Silicon Valley Pig Jig! Retrophin will be our team apron sponsor for the BBQ competition as teams compete to wow our judges and win bragging rights in the BBQ pit.
Retrophin is focused on advancing the development of sparsentan for FSGS. They recently announced that the first patient has been enrolled in the DUPLEX Study, a global, pivotal Phase 3 clinical trial evaluating the long-term nephroprotective potential of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS), a rare kidney disorder that often leads to end-stage renal disease, with no approved pharmacologic treatment available.
We are happy to partner with Retrophin to find a cure for Nephrotic Syndrome (NS) and Focal Segmental Glomerulosclerosis (FSGS). For more information please visit their website Retrophin.